Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-019671
Filing Date
2022-05-12
Accepted
2022-05-12 07:11:17
Documents
60
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sybx-10q_20220331.htm   iXBRL 10-Q 1918281
2 EX-31.1 sybx-ex311_8.htm EX-31.1 16795
3 EX-31.2 sybx-ex312_7.htm EX-31.2 16734
4 EX-32.1 sybx-ex321_9.htm EX-32.1 6980
5 EX-32.2 sybx-ex322_6.htm EX-32.2 6961
6 GRAPHIC gw5j15kfob1j000001.jpg GRAPHIC 62861
  Complete submission text file 0001564590-22-019671.txt   5948169

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA sybx-20220331.xsd EX-101.SCH 37934
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sybx-20220331_cal.xml EX-101.CAL 39850
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sybx-20220331_def.xml EX-101.DEF 133949
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sybx-20220331_lab.xml EX-101.LAB 292038
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sybx-20220331_pre.xml EX-101.PRE 226017
54 EXTRACTED XBRL INSTANCE DOCUMENT sybx-10q_20220331_htm.xml XML 875416
Mailing Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142 617-401-9975
SYNLOGIC, INC. (Filer) CIK: 0001527599 (see all company filings)

EIN.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37566 | Film No.: 22915680
SIC: 2834 Pharmaceutical Preparations